Search Amyloidosis

7151 N. Main St. Ste. 2 Clarkston, MI 48346

Webinars

Cardiac Amyloidosis – What You Need To Know

Hasan K. Siddiqi, MD, MSCR, FACC

Vanderbilt Health, Nashville, TN

The Changing Paradigm of Amyloidosis Treatment

Jeffrey Zonder, MD

Karmanos Cancer Institute, Detroit, MI

Amyloidosis, Past, Present and Future

Giampaolo Merlini, MD

University of Pavia, Italy

Treatment Options in Cardiac Amyloidosis

Martha Grogan, MD

Mayo Clinic, Rochester

Cardiac Amyloidosis: What Every Cardiologist Needs to Know

Grand Rounds with Martha Grogan, MD

Mayo Clinic, Rochester

Amyloidosis: What You Need To Know

Morie Gertz, MD

Mayo Clinic, Rochester

TTR-FAP, The Link Between Neuropathy and Amyloidosis

Courtesy of the Neuropathy Association, Mat Maurer, MD

Columbia University and Michael Polydefkis, MD – Johns Hopkins

TTR Amyloidosis, What Every Patient Must Know

Giampaolo Merlini, MD

University of Pavia, Italy

Diagnosis and Treatment of Amyloidosis

Suzanne Lentzsch, MD PhD

New York Presbyterian Hospital

Amyloidosis 101

Morie Gertz, MD

Mayo Clinic, Rochester

Untangling Amyloidosis

Vaishali Sanchorawala, MD and Frederick L. Ruberg, MD

Boston University/Boston Medical Center Amyloidosis Center

ATTRwt Cardiac Amyloidosis

Mat Maurer, MD

New York-Presbyterian Hospital and Columbia University Medical Center

AMYLOIDOSIS 2030: A SyFy Special

Raymond Comenzo, MD

Tufts University School of Medicine, Boston

PROGRESS IN AMYLOIDOSIS RESEARCH: WHERE ARE WE NOW?

Jeffrey Zonder, MD

Barbara Ann Karmanos Cancer Institute and Wayne State University School of Medicine, Detroit, MI

LIGHT CHAIN (AL) AMYLOIDOSIS: WHAT IS AL ANYWAY?

Heather Landau, MD

Associate Attending Physician Memorial Sloan Kettering, New York, NY

EMERGING TREATMENT LANDSCAPE FOR CARDIAC AMYLOIDOSIS

Mathew S. Maurer, MD

Columbia University Irving Medical Center, New York, NY

ESTABLISHED AND EMERGING TREATMENT STRATEGIES FOR AL AMYLOIDOSIS IN 2021

Heather Landau, MD

Memorial Sloan Kettering, New York, NY

PROGRESS IN AMYLOIDOSIS: 2022

Jeffrey Zonder, MD

Barbara Ann Karmanos Cancer Institute and Wayne State University School of Medicine, Detroit, MI

UPDATES IN ATTR CARDIAC AND NEUROLOGICAL AMYLOIDOSIS: What’s new and exciting for 2022 and beyond

Frederick L. Ruberg, MD, Omar K. Siddiqi, MD, K. H. Vincent Lau, and Michelle Kaku, MD

Boston Medical Center/Boston University – Boston, MA

BEYOND STANDARD OF CARE TREATMENT FOR LIGHT CHAIN (AL) AMYLOIDOSIS: The Promise of Tomorrow

Heather Landau, MD

Memorial Sloan Kettering Cancer Center - New York, NY

UPDATES IN ATTR CARDIAC AMYLOIDOSIS: What’s new and exciting for 2024

Frederick L. Ruberg, MD, Omar K. Siddiqi, MD

Boston Medical Center/Boston University – Boston, MA

Updates in AL amyloidosis: Fast Forward in 2024!

Heather Landau, MD

Memorial Sloan Kettering Cancer Center - New York, NY